ISPUB.com / IJPHARM/8/2/9043
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Pharmacology
  • Volume 8
  • Number 2

Original Article

Effect of roots of Tylophora indica (Burm.f.) on stress and anxiety in animal models

M Kulkarni, A Juvekar

Keywords

anti-stress activity, anxiolytic activity, diazepam, tylophora indica

Citation

M Kulkarni, A Juvekar. Effect of roots of Tylophora indica (Burm.f.) on stress and anxiety in animal models. The Internet Journal of Pharmacology. 2009 Volume 8 Number 2.

Abstract

The anti-stress activity of aqueous extract of Tylophora indica (Burm.f.) (100, 250 and 500 mg/kg) was evaluated using chronic cold restraint stress model in Wistar rats. Standard behavioural paradigms such as elevated plus maze model and light-dark model were employed to study the anxiolytic potential of the test extract in Swiss Albino mice. Stimulation of hypothalamus-pituitary-adrenal axis in stressful condition alters biochemical levels like plasma corticosterone, glucose, proteins, triglyceride, and cholesterol and affects adrenal gland and spleen weights. Pretreatment with test extract at all doses ameliorated these stress-induced biochemical and physiological perturbations in chronic stress model, suggesting its anti-stress potential. Further, the extract at all doses increased the time spent in open arm and lit zone in elevated plus maze and light-dark model respectively, giving an indication of its anxiolytic activity. The promising effects of T. indica extract observed in anti-stress and anxiolytic activities were comparable to reference drug, diazepam.

 

Introduction

Stress is defined as the non-specific response of the body to any demand imposed upon it 1. It is known to alter the physiological homeostasis of the organism and complex mechanisms contribute to the breakdown in adaptational processes resulting in various visceral, endocrinal, and behavioural changes 2. Stress plays the main role in pathogenesis of mental disorders 3,4. A host of chronic psychiatric disease states like melancholic depression, anorexia nervosa, panic disorders, anxiety disorders and cognitive dysfunction have been reported to involve abnormality of stress axis 5. Anxiety disorders in particular, affect 1/8 th of total population worldwide and have become one of important research interest in psychopharmacology during this decade 6. The hallmark of anxiety disorders is marked, persistent and excessive or unreasonable fear that is experienced to a degree that significantly interferes with everyday life 7.

The prevention and management of these stress disorders remains a major clinical problem. Benzodiazepines (BDZs) appear to be effective against acute stress but fail to prevent the consequences of chronic stress. In addition, the problems of tolerance and physical dependence exhibited by BDZs on prolonged use, limit their utility 8. An answer to this vexing problem was first provided when Brekhman and Dardymov reported that some plant-derived agents could induce a state of non specific increase of resistance to affect internal homeostasis. Such agents, named adaptogen have been found to be effective in attenuating stress-induced adverse effects 9. Thus, in the current scenario, finding such adaptogenic agents that possess the ability to combat present day stress disorders along with possessing anxiolytic potential would offer added benefits in psychiatric treatment.

From the vast array of Materia Medica of the indigenous system so many plants have been reported to have activity against CNS disorders and thus act as very useful remedies for the alleviation of human suffering 10. Due to the chronic nature of psychiatric and neurological disorders, the therapeutic action of most psychotropic agents is dependent on long-term treatment and the consequent molecular and cellular adaptations that occur over time 11. In this context, administration of herbal plant-based formulation offers an added edge in treatment considering their cost effectiveness and the mild side effect profile compared to prescription alternatives.

The plant Tylophora indica (Burm.f.) family: Asclepiadaceae is distributed in the plains of southern, central and eastern India. Dried root of the plant have been traditionally useful in treatment of dysentery, asthma and bronchitis 12. Phenanthroindolizidine alkaloids (tylophorine, tylophorinine, and tylophorinidine) present in the roots are the primary bio-active constituents of this plant 13. The indole nucleus and highly lipophilic nature of these alkaloids made the roots of this plant an apt contender for testing its psychopharmacological potential. Since, there is no scientific data regarding effect of roots of the plant on CNS activities, it was thought prudent to investigate its anti-stress and anxiolytic potential in animal models of psychiatric disorders.

Material and methods

Collection of plant material

The roots of Tylophora indica (Burm.f.) family: Asclepiadaceae were obtained from local source and were identified and authenticated at the Department of Botany, Ruia College, Mumbai, India.

Preparation of the plant extract

Dried powdered roots were defatted with Pet ether (60-80°C) and successively extracted with water. The extract so obtained was dried using a vacuum evaporator (40°C) and used for further studies. The aqueous extract for oral administration was prepared in distilled water using 0.2% NaCMC as suspending agent.

Experimental animals

Male Albino Wistar rats (150-200 gm body weight) and male Swiss Albino mice (20-25 gm body weight) were used for anti-stress and anxiolytic activities study respectively. The animals were housed in groups of five in clean polypropylene cage in standard laboratory conditions of temperature (25±2°C) with 12h/12h light and dark cycle. They had free access to food and water ad libitum. The Institutional Animal Ethics Committee (IAEC) approved the experimental protocol.

Acute toxicity studies

Albino Wistar rats (150-200 gm body weight) and Swiss Albino mice (20-25 gm body weight) were used for acute oral toxicity study. The study was carried out as per the guidelines set by OECD and no adverse effects/mortality were detected in both rats and mice upto 5000 mg/kg p.o., during the 24-hr observation period. Based on the results obtained from this study, the doses for anti-stress and anxiolytic activity studies were narrowed down to 100 mg/kg, 250 mg/kg and 500 mg/kg for dose-dependent study.

Anti-stress activity

Experimental design

Wistar rats were divided into six groups of six animals each. Group I animals served as vehicle control and received 0.2% NaCMC in distilled water. Group II animals received 0.2% NaCMC in distilled water and (stress); served as stress control. Group III animals were treated with diazepam (2 mg/kg i.p.) and (stress); served as positive control. Group IV, V and VI were fed orally with aqueous extract [AE] of Tylophora indica [TI] at 100 mg/kg, 250 mg/kg and 500 mg/kg respectively and (stress).

Chronic Cold Restraint Stress (CCRS) model:

After 21 days of pretreatment with vehicle/standard and test extracts to respective groups, same treatment was continued for seven more days and all animals except group I were subjected to chronic cold restraint stress during seven days. Rats were immobilized by placing them in plastic restraint containers which were placed in refrigerator (4°C for 1 hr) for seven continuous days. On the last day, the animals were treated as described earlier, exposed to cold restraint stress and sacrificed. Blood samples were collected to obtain plasma and adrenal gland and spleen were removed to record their weights 14,15.

Anxiolytic activity

Experimental design

Swiss Albino mice were divided into five groups of six each. Group I animals served as vehicle control (0.2% NaCMC). Group II animals were treated with diazepam (1 mg/kg i.p.), served as positive control. Group III, IV and V animals were fed orally with TI[AE] 100 mg/kg, 250 mg/kg and 500 mg/kg respectively. Mice were pretreated for 7 days with respective test extract/std/vehicle before carrying out the study. Drug/vehicle was administered 45 minutes prior to the experiment.

Elevated Plus maze Model (EPM)

The apparatus was a slightly modified version of the original plus-maze used for mice 16. The plus-maze elevated at 50 cm above a base, had four arms (6 cm wide, 16 cm long) extending from a central platform (8 X 8 cm). Two of the arms had side-walls (12 cm high), while the other two arms did not have side-walls. Mice were placed for period of 5 minutes in open arm and number of entries and time spent in open arm was noted 17.

Light-dark model

The mice's light–dark box (30 X 30 X 10 cm) consisted of two parts, the light compartment and the dark-compartment with a volume ratio of 3:1. There was a hole (5 X 5 cm) in the bottom of the clapboard between the two compartments. A 60-W incandescent bulb above provided illumination of 700 lx for the open light-compartment and 0 lx for the enclosed dark compartment. At the start of the experiment, the mouse was placed in the middle of illuminated part of the cage. The number of crossings from dark to light compartment was registered during ten minutes 18.

Statistical analysis

The results obtained in the present study were expressed as the mean ± SD. The numerical results were evaluated by application of One-way Analysis of Variance (ANOVA) with post Bonferroni or Dunnett’s test wherever applicable for statistical significance. P < 0.05 was considered statistical significant.

Results

Anti-stress activity

Chronic cold restraint stress resulted in hypertrophy of adrenal gland and atrophy of spleen in stress control rats. Pretreatment with TI[AE] at (100, 250 and 500 mg/kg) resulted in significant (P < 0.001) reversion of increase in adrenal gland weight and atrophy of spleen caused due to the stress (Table 1).

Table 1: Effect of aqueous extract of Tylophora indica on adrenal gland and spleen organ body weight indices in chronic cold restraint stress rats

Values are mean ± S.D. (n = 6). Significantly different from vehicle control (#P < 0.001), significantly different from stress control group (aP < 0.05; bP < 0.01; cP < 0.001) by one way ANOVA followed by Post Bonferroni test.

Further, pretreatment with TI extract at all doses significantly (P < 0.05; P < 0.01; P < 0.001) restored back chronic cold restraint stress-induced alterations in plasma corticosterone, glucose, total protein, cholesterol and triglyceride levels (Table 2).

Table 2: Effect of pretreatment of aqueous extract of Tylophora indica on chronic cold restraint stress-induced changes in plasma biochemical parameters in rats

Values are mean ± S.D. (n = 6). Significantly different from vehicle control (#P < 0.001), significantly different from stress control group (aP< 0.05, bP<0.01, cP< 0.001) by one way ANOVA followed by Post Bonferroni test.

Anxiolytic activity

Mice pretreated with TI[AE] at (100, 250 and 500 mg/kg) showed significant (P < 0.01) increase in the number of entries and prolongation of the cumulative time spent in the open arm relative to vehicle control mice (Table 3).

Table 3: Effect of aqueous extract of Tylophora indica on exploratory behaviour of mice in elevated plus maze model

Values are mean ± S.D. (n = 6). Significantly different from normal (aP < 0.05, bP < 0.01, cP < 0.001), by one-way ANOVA followed by Dunnett’s Test

Similarly, TI extract treated mice at all the doses showed significantly (P < 0.01) increased number of travellings from dark to light compartment compared to vehicle control mice (Table 4). The effect of test extract observed in both the models were comparable to standard anxiolytic, diazepam.

Table 4: Effect of aqueous extract of Tylophora indica on exploratory behaviour of mice in light-dark model

Values are mean ± S.D. (n = 6). Significantly different from normal (aP< 0.05, bP<0.01, cP< 0.001), by one-way ANOVA followed by Dunnett’s Test

Discussion

A wide variety of stresses, both physical and emotional, act via neural pathways to the hypothalamus to increase corticotropin-releasing hormone (CRH) secretion and hence, adrenocorticotropin hormone (ACTH) and cortisol secretion 19. Release of ACTH in stress stimulates adrenals to increase production of hormones epinephrine, norepinephrine, and corticosteroids 20. These hormones have profound effect on metabolic functions. Adrenaline raises blood sugar, while corticosteroid stimulates glycogenolysis and gluconeogenesis 21. Thus, increased cortisol influences mobilization of stored fat and carbohydrate reserve 22, which in turn increases blood glucose, protein, cholesterol, and triglyceride levels.

Chronic cold restraint stress (CCRS) model was used to deliberate the deleterious effect of chronic stress on the entire body system. Organ body weight indices of adrenal and spleen gland were used as vital markers for studying stress response, as involution of the spleen and increase in adrenal gland weight are primary consequences of chronic stress. The individual or combined weight of adrenal glands is likely to double under the influence of ACTH 23,24. Pretreatment with TI[AE] at all doses reversed increase in adrenal gland weight caused due to stress besides preventing spleen atrophy, thus inhibiting the basic signs of stress response. Likewise, test extract at all doses ameliorated the stress-induced rise in plasma corticosterone, glucose, cholesterol, triglyceride, and total protein levels in CCRS model. Thus, the mitigating effects shown by aqueous extract of T. indica on chronic stress-induced biochemical and physiological perturbations gives a clear indication of its anti-stress activity. Further, this effect of test extract was found to be comparable to that of diazepam, the conventional adaptogenic agent.

The two experimental models of anxiety, elevated plus maze and light and dark arena, are based on the assumption that unfamiliar, non-protective and brightly lit environmental stress provokes inhibition of normal behaviour. This normal behavioural inhibition is further augmented in the presence of fear or anxiety like state 25. In the elevated plus maze, the open arms are more fear provoking than the closed arms. It has been observed that anxiolytic drugs, diazepam-like, increase the number of arm entries and percentage of time spend in the open arms of an elevated plus maze and anxiogenic drugs have opposite effect 26. In the light and dark box paradigm, the brightly lit environment is a noxious environment stressor that inhibits the exploratory behaviour of rodents. Reduction in the number of entries and time spent in the light chamber are regarded as markers of anxiety 27.

Mice pretreated with TI extract at all the doses showed increase in number of entries and total time spent in open arm in elevated plus maze model. In addition, test extract treated group demonstrated increased number of travellings from dark chamber to light chamber in light-dark model. The behavioural changes in both the models indicative of decreased fear and decreased aversion to bright light, suggests the anxiolytic potency of the extract. The validity of both the anxiolytic models was supported by the observation that diazepam, a classical anxiolytic, showed preference to open arm and light chamber in elevated plus maze and light-dark model respectively.

Conclusion

In conclusion, the present study indicated that aqueous extract of roots of Tylophora indica possess significant anti-stress and anxiolytic activities. The plant can thus, be considered as a valuable contribution to the existing armamentarium of very few agents that possess combination of psychopharmacological activities. Further, this dual potential of T. indica extract may bear a potential clinical use in management of stressed patients suffering from anxiety disorders or vice versa.

References

1. Selye, H., 1973. The evolution of the stress. American Scientist 61, 692-695.
2. Chrousos, G.P., Gold, P.W., 1992. The concept of stress and stress system disorders. Overview of physical and behavioral homeostasis. J. A. M. A. 267(9), 1244-1252.
3. McKinney, W.T., 1984. Animal models of depression: an overview. Psychiatry 2, 77-96.
4. Willner, P., 1997. Validity, reliability and utility of chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl.) 134(4), 319-329.
5. Kulkarni, S.K., Kaur, G., 2000. Differential effect of a polyherbal formulation-OB-200G in male and female mice subjected to forced swim stress. Indian J. Physiol. Pharmacol. 44(3), 281-289.
6. Cha, H-Y., Seo, J-J., Park, J-H., Choi, K-J., Hong, J-T., Oh, K-W., 2004. Anxiolytic effects of total saponin fraction from Ginseng Radix Rubra on the elevated plus-maze model in mice. J. Ginseng Res. 28, 132-135.
7. Cryan, J.F., Holmes, A., 2005. The ascent of mouse: advances in modeling human depression and anxiety. Nature reviews Drug discovery 4, 775-790.
8. Mc Carty, R., 1989. Stress research: principles, problems and prospects. In: Van Loon, G.R., Kvetnansky, R.R., McCarty, R., Axelrod, J., (eds.) Stress neurochemical and humoral mechanism, Gordan and Breach Science Publishers, New York, 3.
9. Brekhman, I.I., Dardymov, I.V., 1969. New substances of plant origin which increase nonspecific resistance. Annu. Rev. Pharmacol. Toxicol. 9, 419-429.
10. Suba, V., Murugesan, T., Rao, R.B., Pal, M., Mandal, S.C., Saha, B.P., 2002. Neuropharmacological profile of Barleria lupulina Lindl. extract in animal models. J. Ethnopharmacol. 81(2), 251-255.
11. Duman, R.S., 1999. Neuropharmacology in the next millennium: Promise for breakthrough discoveries. Neuropsychopharmacol. 20(2), 97-98.
12. Bhattacharjee, S.K., 2001. Handbook of aromatic plants, 3rd ed, Pointer publishers, Jaipur, India, 358-359.
13. Ratnagiriswaran, H.N., Venkatachalam, K., 1935. The chemical examination of Tylophora asthmatica & isolation of the alkaloids Tylophorine & Tylophorinine. Indian J. Med. Res. 22, 433-441.
14. Kannur, D.M., Hukkeri, V.I., Akki, K.S., 2006. Adaptogenic activity of Caesalpinia bonduc seed extracts in rats. J. Ethnopharmacol. 108(3), 327-331.
15. Nimbkar, S.R., Patki, V.P., Patki, M.P., 2001. Pharmacological evaluation of anti-stress and androgenic activity of polyherbal formulation ‘A.P-3000’ containing Panax ginseng. Indian Drugs 38, 27-31.
16. Lister, R.G., 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl). 92(2), 180-185.
17. Maruyama, Y., Kuribara, H., Kishi, E., Weintraub, S.T., Ito, Y., 2001. Confirmation of the anxiolytic-like effect of dihydrohonokiol following behavioural and biochemical assessments. J. Pharm. Pharmacol. 53(5), 721-725.
18. Gong, Z., Li, Y., Zhao, N., Yang, H., Su, R., Luo, Z., Li, J., 2006. Anxiolytic effect of agmatine in rats and mice. Eur. J. Pharmacol. 550, 112-116.
19. Bhatwadekar, A.D., Chintawar, S.D., Logade, N.A., Somani, R.S., Kasture, V.S., Kasture, S.B., 1999. Anti-stress activity of Butea monosperma flowers. Indian J. Pharmacol. 31(2), 153-155.
20. Rang, H.P., Dale, M.M., 1996. The endocrine system. In: Rang, H.P., Dale, M.M., Riter, J.M., (eds.) Pharmacology, 3rd ed, Churchill Livingstone, London, 417-453.
21. Sharma, V.N., Godhawani, J.L., 1970. Stress induced changes in catecholamine, glycogen and blood glucose levels and their modification by antiadrenergic drugs. Indian J. Med. Res. 58, 1063-1072.
22. Tache, Y., Du Ruisseau, P., Tache, J., Selye, H., Collu, R., 1976. Shift in adenohypophyseal activity during chronic intermittent immobilization of rats. Neuroendocrinology 22(4), 325-336.
23. Worstman, J., Frank, S., Cryer, P.E., 1984. Adrenomedullary response to maximal stress in humans. Am. J. Med. 77(5), 779-782.
24. Natelson, B.H., Tapp, W.N., Adamus, J.E., Mittler, J.C., Levin, B.E., 1981. Humoral indices of stress in rats. Physiol. Behav. 26(6), 1049-1057.
25. Gopala Krishna, H.N., Sangha, R.B., Misra, N., Pai, M., 2006. Antianxiety effect of NR-ANX- C, a polyherbal preparation in rats. Indian J. Pharmacol. 38(5), 330-335.
26. Zangrossi, H., File, S.E., 1992. Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res. Bull. 29, 381-388.
27. Costall, B., Domeney, A.M., Gerrard, P.A., Kelly, M.E., Naylor, R.J., 1988. Zacopride: anxiolytic profile in rodent and primate models of anxiety. J. Pharm. Pharmacol. 40(4), 302-305.

Author Information

Mrugaya P. Kulkarni, M.Pharm
Department of Pharmaceutical Sciences and Technology, Mumbai University Institute of Chemical Technology

Archana R. Juvekar, Ph.D
Department of Pharmaceutical Sciences and Technology, Mumbai University Institute of Chemical Technology

Your free access to ISPUB is funded by the following advertisements:

Advertisement

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy

Close

Enter the site

Login

Password

Remember me

Forgot password?

Login

SIGN IN AS A USER

Use your account on the social network Facebook, to create a profile on BusinessPress